Panel: Powering Biologic Breakthroughs by Process, Analytical and CMC Innovation

Session details:

The rise of complex biologics from bispecifics and ADCs to gene and cell therapies is driving a seismic shift in analytical development. Biotech companies increasingly rely on external innovation and expert partners to meet evolving analytical, regulatory, and speed-to-market demands. This panel will explore how cutting-edge analytical strategies, smart outsourcing models, and technology-enabled solutions are redefining biologic development—from discovery to commercialization.

• Evolving needs of biotech sponsors: where vendors can drive the most value
• Trends in outsourcing analytical development for CGTs, bispecifics, and ADCs
• Innovation in platforms: multi-attribute methods, real-time analytics, and AI integration
• Integrating AI/ML, automation, and data tools to streamline analytical development
• Meeting global regulatory expectations with robust, scalable service offerings